Welcome to our dedicated page for Mei Pharma SEC filings (Ticker: MEIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lite Strategy, Inc. filings document the company’s corporate transition from MEI Pharma, including the amended certificate of incorporation that changed its name and the Nasdaq ticker change from MEIP to LITS. Recent 8-K disclosures also record its Litecoin treasury reserve strategy, related Regulation FD announcements, and financial-results reporting tied to treasury operations.
The company’s filings cover material agreements and capital-structure matters, including a private placement of common stock and pre-funded warrants, the GSR asset-management relationship, and a BitGo Prime master loan framework for digital assets or cash. Governance disclosures include board changes, stockholder voting results, and approval of the 2026 Omnibus Equity Compensation Plan.
Amendment No. 9 to Schedule 13D – MEIP (filed 24-Jul-25)
The Cable Car/Anson activist coalition discloses that MEI Pharma’s 17-Jul-25 private placement diluted its combined stake below the 5 % reporting threshold. The group now owns 1,093,188 shares, or 3.7 % of the 29,879,755 shares outstanding, and therefore ceases to act as a Section 13(d) group. Individual holdings: Funicular Funds/Cable Car/J. Ma-Weaver 35,300 sh (0.1 %); Anson Investments Master 841,674 sh (2.8 %); Anson East Master 214,304 sh (0.7 %); Anson Opportunities Master 37,210 sh (0.1 %).
Because the “Minimum Ownership Amount” in the 2023 Cooperation Agreement was no longer satisfied, Anson-appointed director Taheer Datoo resigned effective 22-Jul-25. On the same date all parties executed mutual terminations of both the Cooperation Agreement and the Group Agreement. Each fund acquired its position for cash (≈ US $12.9 m aggregate) without margin financing and now disclaims beneficial ownership of shares it does not directly hold.
Implication: activist governance pressure and mandatory 13D amendments end, reducing the likelihood of further board or strategic agitation from these investors.